logo.jpg
Processa Pharmaceuticals Provides Corporate Update and Announces Year End 2022 Financial Results
March 30, 2023 16:01 ET | Processa Pharmaceuticals, Inc.
Company focused on the development of Next Generation Chemotherapy drugs in 2023 and out-licensing/business development efforts for non-oncology assets.Dose escalations continue for Next Generation...
Palisade Bio_Logos(4.22)VSM.png
Palisade Bio Reports Year End 2022 Financial Results and Provides Corporate Update
March 23, 2023 08:05 ET | Palisade Bio, Inc.
Phase 2 topline data readout for prevention of post-surgical abdominal adhesions on track for Q2 2023 Strong balance sheet with sufficient cash expected to fund operations into mid-2024 ...
Logo.jpg
ST. JAMES GOLD CORP. (TSXV: LORD) PROVIDES CORPORATE UPDATE
March 22, 2023 08:00 ET | St. James Gold Corp.
Vancouver, British Columbia, March 22, 2023 (GLOBE NEWSWIRE) -- St. James Gold Corp. (the “Company”) (TSXV: LORD) (OTCQB: LRDJF) (FSE: BVU3) is pleased to provide a corporate update and outlook for...
logo.jpg
AC Immune Reports Full Year 2022 Financial Results and Provides Corporate Update
March 16, 2023 07:00 ET | AC Immune SA
AC Immune Reports Full Year 2022 Financial Results and Provides Corporate Update Clinical-stage vaccine programs targeting amyloid-beta (Abeta), phosphorylated-Tau (pTau), and alpha-synuclein...
FINAL_VeruIncLogo_RGB_300dpi.jpg
Veru to Present at the Oppenheimer 33rd Annual Healthcare Conference
March 07, 2023 08:30 ET | Veru Inc.
MIAMI, FL., March 07, 2023 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for COVID-19 and other viral ARDS-related diseases and for...
abaxx logo.png
Abaxx Provides Corporate Update and Quarterly Development Activities
February 22, 2023 08:00 ET | Abaxx Technologies Inc.
TORONTO, Feb. 22, 2023 (GLOBE NEWSWIRE) -- Abaxx Technologies Inc. (NEO:ABXX)(OTCQX:ABXXF) (“Abaxx” or the “Company”), a financial software and market infrastructure company, majority shareholder of...
Project Map
Atlas Salt Corporate Update
February 21, 2023 08:45 ET | Atlas Salt Inc.
ST. JOHN’S, Newfoundland and Labrador, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Atlas Salt (the “Company” or “Atlas” - TSXV: SALT; OTCQB: REMRF), 100% owner of North America’s premier undeveloped...
Foothills.jpg
FOOTHILLS EXPLORATION, INC. ANNOUNCES CORPORATE UPDATE
January 27, 2023 08:00 ET | Foothills Exploration, Inc
LOS ANGELES, Jan. 27, 2023 (GLOBE NEWSWIRE) -- Foothills Exploration, Inc. (OTC: FTXP), including its direct and indirect subsidiaries, (“Foothills,” or the “Company”), an oil and gas exploration...
logo.jpg
RYVYL Provides Corporate Update on Restatement of Previously Issued Financial Statements
January 25, 2023 08:00 ET | RYVYL Inc.
Restatements will not impact cash, operating margins or processing volume SAN DIEGO, CA, Jan. 25, 2023 (GLOBE NEWSWIRE) -- RYVYL Inc. (NASDAQ: RVYL) ("RYVYL” or the "Company"), a company that...
Logo.jpg
Ocean Biomedical Provides Corporate Update and Company Summary
January 24, 2023 09:15 ET | Aesther Healthcare Acquisition Corp.
Ocean Biomedical stock is expected to trade on the Nasdaq Capital Market under ticker symbol "OCEA" PROVIDENCE, RI and NEW YORK, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Ocean Biomedical (“Ocean”), a...